首页> 外文期刊>Technology in cancer research & treatment. >Feasibility of Identification of Gamma Knife Planning Strategies by Identification of Pareto Optimal Gamma Knife Plans
【24h】

Feasibility of Identification of Gamma Knife Planning Strategies by Identification of Pareto Optimal Gamma Knife Plans

机译:通过确定帕累托最优伽玛刀计划来确定伽玛刀计划策略的可行性

获取原文
           

摘要

The use of conformity indices to optimize Gamma Knife planning is common, but does not address important tradeoffs between dose to tumor and normal tissue. Pareto analysis has been used for this purpose in other applications, but not for Gamma Knife (GK) planning. The goal of this work is to use computer models to show that Pareto analysis may be feasible for GK planning to identify dosimetric tradeoffs. We define a GK plan A to be Pareto dominant to B if the prescription isodose volume of A covers more tumor but not more normal tissue than B, or if A covers less normal tissue but not less tumor than B. A plan is Pareto optimal if it is not dominated by any other plan. Two different Pareto optimal plans represent different tradeoffs between dose to tumor and normal tissue, because neither plan dominates the other. ‘GK simulator’ software calculated dose distributions for GK plans, and was called repetitively by a genetic algorithm to calculate Pareto dominant plans. Three irregular tumor shapes were tested in 17 trials using various combinations of shots. The mean number of Pareto dominant plans/trial was 59 ± 17 (sd). Different planning strategies were identified by large differences in shot positions, and 70 of the 153 coordinate plots (46%) showed differences of 5mm or more. The Pareto dominant plans dominated other nearby plans. Pareto dominant plans represent different dosimetric tradeoffs and can be systematically calculated using genetic algorithms. Automatic identification of non-intuitive planning strategies may be feasible with these methods.
机译:通常使用合格指数来优化伽玛刀的计划,但是并未解决在肿瘤剂量与正常组织之间的重要权衡问题。帕累托分析已在其他应用程序中用于此目的,但尚未用于伽玛刀(GK)规划。这项工作的目的是使用计算机模型来证明帕累托分析对于GK计划确定剂量学权衡是可行的。如果A的处方等剂量体积比B覆盖更多的肿瘤但不多于正常组织,或者如果A覆盖的正常组织少但不比B少,则我们将GK计划A定义为B的帕累托优势。它不受任何其他计划支配。两种不同的帕累托最优计划代表着在肿瘤剂量与正常组织剂量之间的不同权衡,因为这两个计划都不占主导。 “ GK仿真器”软件计算了GK计划的剂量分布,并被遗传算法重复调用以计算Pareto主导计划。在17种试验中使用不同的注射组合测试了三种不规则的肿瘤形状。帕累托优势计划/试验的平均数量为59±17(sd)。通过不同的射击位置来确定不同的计划策略,并且在153个坐标图中有70个(46%)显示出5mm或更大的差异。帕累托占主导地位的计划主导了其他附近的计划。帕累托优势计划代表了不同的剂量权衡,可以使用遗传算法进行系统地计算。这些方法可以自动识别非直觉的计划策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号